Akari TherapeuticsAKTX
13F holders, Q1 2025 (March 31)11holders −3
1new positions
4sold out
1famous investor
$1.24avg. 13F price*
At the end of Q1 2025, 11 institutions reported holding Akari Therapeutics PLC (AKTX) in their 13F filings, down 3 from Q4 2024. 1 opened new positions and 4 sold out. The largest holders were Palo Alto Investors LP ($181K), Omnia Family Wealth, LLC ($109K) and Cerity Partners LLC ($29K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Akari Therapeutics PLC
- CUSIP
- 00972G207
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 4 | $16K |
All 13F filers, Q4 2024 → Q1 2025: 100 shares bought and 18,485 shares sold, net −18,385 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Palo Alto Investors LP | 0.03% | No change | 146,024 | $181K |
| Omnia Family Wealth, LLC | 0.05% | No change | 87,628 | $109K |
| Cerity Partners LLC | 0.00% | No change | 23,643 | $29K |
| Cresset Asset Management, LLC | 0.00% | No change | 18,408 | $23K |
| Renaissance Technologies | 0.00% | Reduce -21.6% | 18,384 | $23K |
| Accent Capital Management, LLC | 0.01% | No change | 10,000 | $12K |
| Bank of America Corp. | 0.00% | No change | 150 | $186 |
| Truvestments Capital LLC | 0.00% | No change | 50 | $62 |
| Morgan Stanley | 0.00% | No change | 6 | $7 |
| Cornerstone Planning Group LLC | 0.00% | No change | 5 | $7 |
| Royal Bank of Canada | 0.00% | New | 100 | $0 |
"% of holder's portfolio" is AKTX's weight in each manager's 13F, not the share of Akari Therapeutics PLC the manager owns.